Future Medicine (Drug Discovery) is Drug Discovery in South Korea that focus on South Korea business. Founded in 2015. They cover business area such as developer, synthetic drug, Seongnam, South Korea, new novel target, anti-inflammatory/anti, fibrosis, non-alcoholic hepatitis, (nash, oral glaucoma treatment, chronic kidney disease treatment, targeted and Immuno cancer drug.
2015
( 9 years old in 2024 )
South Korea
-
Rm 616 LH-Business Growth Center
54 changup-ro, Sujeong-gu, Gyeonggi-do
Seongnam, 13449
South Korea
Private
developersynthetic drugSeongnamSouth Koreanew novel targetanti-inflammatory/antifibrosisnon-alcoholic hepatitis(nashoral glaucoma treatmentchronic kidney disease treatmenttargeted and Immuno cancer drug
* We use standard office opening hours in near Future Medicine (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Future Medicine (Drug Discovery) is Drug Discovery business from South Korea that founded in 2015 (9 years old in 2024), Future Medicine (Drug Discovery) business is focusing on South Korea.
Future Medicine (Drug Discovery) headquarter office and corporate office address is located in Rm 616 LH-Business Growth Center 54 changup-ro, Sujeong-gu, Gyeonggi-do Seongnam, 13449 South Korea.
Future Medicine (Drug Discovery) was founded in South Korea.
In 2024, Future Medicine (Drug Discovery) is currently focus on South Korea sector.
Above is snippet of Google Trends for "South Korea" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Future Medicine (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.